Revolutionising cytogenetic analysis with Applied Spectral Imaging (ASI)

In this presentation from the Association for Clinical Genomic Science (ACGS) 2025 conference, OGT expert Chris Harrigan provides insight into the latest advancements in cytogenetic analysis from our partner* Applied Spectral Imaging (ASI), a global leader in advanced biomedical imaging.

ASI have developed a number of cutting-edge technologies — including scanners and software analysis solutions for fluorescence in situ hybridisation (FISH) and karyotyping — primarily designed to reduce turnaround time, but also to address the challenge labs face with ever increasing sample volumes.

During the presentation Chris details how HiBand — ASI’s digital chromosome analysis and karyotyping system — can streamline a lab’s cytogenetic workflows and deliver improved efficiency with AI-based karyotyping, including:

• AI-powered chromosome segmentation achieving 94% accuracy in blood samples and 90% accuracy in bone marrow
• AI-powered chromosome classification† achieving 99% accuracy in blood samples and 96% accuracy in bone marrow
• Average time required to correct one metaphase (segmentation and placement) reduced by around 60% for peripheral blood and 50% for bone marrow

Discover more about our partnership with ASI

* ASI products are available via OGT in Great Britain (England, Scotland and Wales) only.

† Following corrected segmentation